High dose of human plasma‐derived FVIII‐VWF as first‐line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review. (11th October 2012) - Zanon, E.; Milan, M.; Brandolin, B.; Barbar, S.; Spiezia, L.; Saggiorato, G.; Simioni, P.; Baudo, F.